Diagnostic Imaging of Hepatocellular Carcinoma: Recent Progress

Oncology ◽  
2011 ◽  
Vol 81 (s1) ◽  
pp. 73-85 ◽  
Author(s):  
Masatoshi Kudo
2019 ◽  
Vol 2019 ◽  
Author(s):  
Adriano De Santis ◽  
Giulia Gallusi

2016 ◽  
Vol 11 (1) ◽  
pp. 1-14
Author(s):  
Daniel Trabulo ◽  
Pedro Santos ◽  
Afonso Gonçalves ◽  
Isabel Távora

2013 ◽  
Vol 7 ◽  
pp. CMO.S7633 ◽  
Author(s):  
Zhengyu Wei ◽  
Cataldo Doria ◽  
Yuan Liu

Hepatocellular carcinoma (HCC) is the most common liver cancer and the third leading cause of cancer death. It has been a major worldwide health problem with more new cases being diagnosed each year. The current available therapies for patients with advanced HCC are extremely limited. Therefore, it is of great clinical interests to develop more effective therapies for systemic treatment of advanced HCC. Several promising target-based drugs have been tested in a number of clinical trials. One breakthrough of these efforts is the approved clinical use of sorafenib in patients with advanced HCC. Targeted therapies are becoming an attractive option for the treatment of advanced HCC. In this review, we summarize the most recent progress in clinical targeted treatments of advanced HCC.


2011 ◽  
Vol 7 (3) ◽  
pp. 155-160 ◽  
Author(s):  
Nader N. Massarweh ◽  
James O. Park ◽  
Jordi Bruix ◽  
Raymond S.W. Yeung ◽  
Ruth B. Etzioni ◽  
...  

Understanding the factors that drive biopsy use may help improve the care of patients with hepatocellular carcinoma.


1992 ◽  
Vol 17 (5) ◽  
pp. 416
Author(s):  
VANI VIJAYAKUMAR ◽  
CARLOS BEKERMAN ◽  
LOKENDRA N CHOWDHURY

Sign in / Sign up

Export Citation Format

Share Document